Bare Financial Services’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.67K Hold
148
﹤0.01% 802
2026
Q1
$3.14K Sell
148
-15
-9% -$300 ﹤0.01% 832
2025
Q4
$2.66K Buy
163
+70
+75% +$1.06K ﹤0.01% 766
2025
Q3
$1.09K Hold
93
﹤0.01% 995
2025
Q2
$1.08K Buy
+93
New +$848 ﹤0.01% 902

Other funds holding TXG

Bare Financial Services's TXG Position: Q2 2026 in Review

Bare Financial Services held its 10x Genomics (TXG) position steady in Q2 2026 at 148 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #802.

Bare Financial Services first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bare Financial Services held 148 shares of 10x Genomics worth $5.67K as of Q2 2026.
  • Bare Financial Services left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #802 holding.
  • Bare Financial Services first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.